Loading…

Loading grant details…

Active HORIZON European Commission

Novel precision fermentation process to produce animal-free bioidentical ovalbumin


Funder European Commission
Recipient Organization Onego Bio Ltd
Country Finland
Start Date Jan 01, 2025
End Date Dec 31, 2026
Duration 729 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101188965
Grant Description

Eggs are critically important in the global food system due to functional and nutritional properties; yet the egg market and supply chains are in crisis due to cage-free requirements and avian flu. Onego Bio will make it possible to manufacture egg protein entirely animal-free.

We developed a highly-scalable precision fermentation process using the patented Trichoderma reesei cellular-based production to produce animal-free ovalbumin.

We produce bioidentical egg protein with cost parity and 87% lower CO2 emissions compared to traditional animal-derived eggs.Ovalbumin is the most important egg protein, responsible for the essential ingredient performance.

This single protein ovalbumin can solve all current challenges in the egg market and supply chain.Our product, Bioalbumen provides the nutritional and functional upsides of egg protein, without the environmental, ethical and safety-related drawbacks. Our manufacturing method stabilises the food supply chain and increases food security.

All Grantees

Onego Bio Ltd

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant